ID   CNDP1_HUMAN             Reviewed;         507 AA.
AC   Q96KN2; Q14D40; Q17S05; Q2TBG0; Q6UWK2; Q9BT98;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 4.
DT   10-MAY-2017, entry version 137.
DE   RecName: Full=Beta-Ala-His dipeptidase;
DE            EC=3.4.13.20;
DE   AltName: Full=CNDP dipeptidase 1;
DE   AltName: Full=Carnosine dipeptidase 1;
DE   AltName: Full=Glutamate carboxypeptidase-like protein 2;
DE   AltName: Full=Serum carnosinase;
DE   Flags: Precursor;
GN   Name=CNDP1; Synonyms=CN1, CPGL2; ORFNames=UNQ1915/PRO4380;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-113.
RC   TISSUE=Brain;
RA   Chen J.M., Barrett A.J.;
RT   "Cloning and sequencing of a second human homologue of glutamate
RT   carboxypeptidase in peptidase family M20.";
RL   Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], POLYMORPHISM, AND VARIANTS LEU-20 INS AND
RP   VAL-113.
RX   PubMed=16046297; DOI=10.2337/diabetes.54.8.2320;
RA   Janssen B., Hohenadel D., Brinkkoetter P., Peters V., Rind N.,
RA   Fischer C., Rychlik I., Cerna M., Romzova M., de Heer E., Baelde H.,
RA   Bakker S.J., Zirie M., Rondeau E., Mathieson P., Saleem M.A.,
RA   Meyer J., Koppel H., Sauerhoefer S., Bartram C.R., Nawroth P.,
RA   Hammes H.P., Yard B.A., Zschocke J., van der Woude F.J.;
RT   "Carnosine as a protective factor in diabetic nephropathy: association
RT   with a leucine repeat of the carnosinase gene CNDP1.";
RL   Diabetes 54:2320-2327(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-113.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LEU-20 INS AND
RP   VAL-113.
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHARACTERIZATION, SUBUNIT, AND CATALYTIC ACTIVITY.
RX   PubMed=7116644; DOI=10.1016/0009-8981(82)90166-8;
RA   Lenney J.F., George R.P., Weiss A.M., Kucera C.M., Chan P.W.,
RA   Rinzler G.S.;
RT   "Human serum carnosinase: characterization, distinction from cellular
RT   carnosinase, and activation by cadmium.";
RL   Clin. Chim. Acta 123:221-231(1982).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=6616870; DOI=10.1016/0009-8981(83)90243-7;
RA   Lenney J.F., Peppers S.C., Kucera C.M., Sjaastad O.;
RT   "Homocarnosinosis: lack of serum carnosinase is the defect probably
RT   responsible for elevated brain and CSF homocarnosine.";
RL   Clin. Chim. Acta 132:157-165(1983).
RN   [8]
RP   BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, CATALYTIC ACTIVITY,
RP   AND MUTAGENESIS OF HIS-132; ASP-165 AND GLU-200.
RX   PubMed=12473676; DOI=10.1074/jbc.M209764200;
RA   Teufel M., Saudek V., Ledig J.P., Bernhardt A., Boularand S.,
RA   Carreau A., Cairns N.J., Carter C., Cowley D.J., Duverger D.,
RA   Ganzhorn A.J., Guenet C., Heintzelmann B., Laucher V., Sauvage C.,
RA   Smirnova T.;
RT   "Sequence identification and characterization of human carnosinase and
RT   a closely related non-specific dipeptidase.";
RL   J. Biol. Chem. 278:6521-6531(2003).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-322 AND ASN-382.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.26 ANGSTROMS) OF 27-507 IN COMPLEX WITH ZINC
RP   IONS, AND COFACTOR.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human carnosine dipeptidase 1.";
RL   Submitted (JUL-2011) to the PDB data bank.
CC   -!- CATALYTIC ACTIVITY: Preferential hydrolysis of the beta-Ala-|-His
CC       dipeptide (carnosine), and also anserine, Xaa-|-His dipeptides and
CC       other dipeptides including homocarnosine.
CC       {ECO:0000269|PubMed:12473676, ECO:0000269|PubMed:7116644}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|Ref.10};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000269|Ref.10};
CC   -!- ENZYME REGULATION: Inhibited by the metal chelator 1,10-o-
CC       phenantrolin. The inhibitory concentration 50% (IC(50)) is 5 uM.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.27 uM for carnosine (at 30 degrees Celsius and in the
CC         absence of cadmium ions) {ECO:0000269|PubMed:12473676};
CC         KM=11.00 uM for carnosine (at 30 degrees Celsius and in the
CC         presence of 200 uM cadmium ions) {ECO:0000269|PubMed:12473676};
CC         KM=0.20 uM for homocarnosine (at 30 degrees Celsius and in the
CC         absence of cadmium ions) {ECO:0000269|PubMed:12473676};
CC         KM=1.0 uM for homocarnosine (at 30 degrees Celsius and in the
CC         presence of 200 uM cadmium ions) {ECO:0000269|PubMed:12473676};
CC         Note=1 hour incubation in 50 mM Tris-HCl, pH 7.5.;
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:12473676};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:7116644,
CC       ECO:0000269|Ref.10}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Found in serum and adult nervous central
CC       system. Absent in serum from patients with homocarnosinosis.
CC       {ECO:0000269|PubMed:12473676, ECO:0000269|PubMed:6616870}.
CC   -!- POLYMORPHISM: The number of trinucleotide (CTG) repeat varies
CC       among different alleles leading to insertion of Leu residues in
CC       the signal peptide. The allele with 5 leucines (as shown in the
CC       reference entry) is known as the Mannheim allele. Diabetic
CC       patients with the CNDP1 Mannheim allele are less susceptible for
CC       nephropathy. {ECO:0000269|PubMed:16046297}.
CC   -!- SIMILARITY: Belongs to the peptidase M20A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ417564; CAD10388.1; -; mRNA.
DR   EMBL; AY358756; AAQ89116.1; -; mRNA.
DR   EMBL; BC004271; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC110295; AAI10296.1; -; mRNA.
DR   EMBL; BC113512; AAI13513.1; -; mRNA.
DR   EMBL; BC117122; AAI17123.1; -; mRNA.
DR   CCDS; CCDS12007.1; -.
DR   RefSeq; NP_116038.4; NM_032649.5.
DR   UniGene; Hs.400613; -.
DR   PDB; 3DLJ; X-ray; 2.26 A; A/B=27-507.
DR   PDBsum; 3DLJ; -.
DR   ProteinModelPortal; Q96KN2; -.
DR   SMR; Q96KN2; -.
DR   BioGrid; 124230; 16.
DR   STRING; 9606.ENSP00000351682; -.
DR   MEROPS; M20.006; -.
DR   iPTMnet; Q96KN2; -.
DR   PhosphoSitePlus; Q96KN2; -.
DR   BioMuta; CNDP1; -.
DR   DMDM; 317373563; -.
DR   PaxDb; Q96KN2; -.
DR   PeptideAtlas; Q96KN2; -.
DR   PRIDE; Q96KN2; -.
DR   DNASU; 84735; -.
DR   Ensembl; ENST00000358821; ENSP00000351682; ENSG00000150656.
DR   GeneID; 84735; -.
DR   KEGG; hsa:84735; -.
DR   UCSC; uc002llq.5; human.
DR   CTD; 84735; -.
DR   DisGeNET; 84735; -.
DR   GeneCards; CNDP1; -.
DR   HGNC; HGNC:20675; CNDP1.
DR   HPA; HPA008933; -.
DR   MIM; 609064; gene.
DR   neXtProt; NX_Q96KN2; -.
DR   PharmGKB; PA134907547; -.
DR   eggNOG; KOG2276; Eukaryota.
DR   eggNOG; COG0624; LUCA.
DR   HOGENOM; HOG000216709; -.
DR   HOVERGEN; HBG051103; -.
DR   InParanoid; Q96KN2; -.
DR   KO; K05604; -.
DR   OrthoDB; EOG091G05RU; -.
DR   PhylomeDB; Q96KN2; -.
DR   TreeFam; TF300633; -.
DR   BioCyc; MetaCyc:HS07681-MONOMER; -.
DR   BRENDA; 3.4.13.20; 2681.
DR   SABIO-RK; Q96KN2; -.
DR   EvolutionaryTrace; Q96KN2; -.
DR   GeneWiki; CNDP1; -.
DR   GenomeRNAi; 84735; -.
DR   PRO; PR:Q96KN2; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000150656; -.
DR   CleanEx; HS_CNDP1; -.
DR   ExpressionAtlas; Q96KN2; baseline and differential.
DR   Genevisible; Q96KN2; HS.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004180; F:carboxypeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016805; F:dipeptidase activity; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IDA:MGI.
DR   GO; GO:0032268; P:regulation of cellular protein metabolic process; IDA:MGI.
DR   CDD; cd05676; M20_dipept_like_CNDP; 1.
DR   InterPro; IPR001261; ArgE/DapE_CS.
DR   InterPro; IPR017153; CNDP/DUG1.
DR   InterPro; IPR002933; Peptidase_M20.
DR   InterPro; IPR011650; Peptidase_M20_dimer.
DR   Pfam; PF07687; M20_dimer; 1.
DR   Pfam; PF01546; Peptidase_M20; 1.
DR   PIRSF; PIRSF037242; CNDP_dipeptidase; 1.
DR   PROSITE; PS00759; ARGE_DAPE_CPG2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carboxypeptidase; Complete proteome; Glycoprotein;
KW   Hydrolase; Metal-binding; Metalloprotease; Phosphoprotein;
KW   Polymorphism; Protease; Reference proteome; Secreted; Signal; Zinc.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    507       Beta-Ala-His dipeptidase.
FT                                /FTId=PRO_0000026809.
FT   ACT_SITE    134    134       {ECO:0000250}.
FT   ACT_SITE    199    199       Proton acceptor. {ECO:0000250}.
FT   METAL       132    132       Zinc 2.
FT   METAL       165    165       Zinc 1.
FT   METAL       165    165       Zinc 2.
FT   METAL       200    200       Zinc 1.
FT   METAL       228    228       Zinc 2.
FT   METAL       478    478       Zinc 1.
FT   MOD_RES     219    219       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q66HG3}.
FT   CARBOHYD    322    322       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    382    382       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   VARIANT       6      6       G -> R (in dbSNP:rs11151964).
FT                                /FTId=VAR_027147.
FT   VARIANT      20     20       L -> LL. {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16046297}.
FT                                /FTId=VAR_027148.
FT   VARIANT     113    113       I -> V (in dbSNP:rs4263028).
FT                                {ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16046297,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_027149.
FT   MUTAGEN     132    132       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12473676}.
FT   MUTAGEN     165    165       D->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12473676}.
FT   MUTAGEN     200    200       E->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12473676}.
FT   CONFLICT    155    155       D -> G (in Ref. 1; CAD10388 and 5;
FT                                AAI10296). {ECO:0000305}.
FT   CONFLICT    237    237       P -> L (in Ref. 1; CAD10388).
FT                                {ECO:0000305}.
FT   CONFLICT    272    272       P -> L (in Ref. 1; CAD10388).
FT                                {ECO:0000305}.
FT   HELIX        35     44       {ECO:0000244|PDB:3DLJ}.
FT   HELIX        46     57       {ECO:0000244|PDB:3DLJ}.
FT   STRAND       62     65       {ECO:0000244|PDB:3DLJ}.
FT   HELIX        68     87       {ECO:0000244|PDB:3DLJ}.
FT   STRAND       91     95       {ECO:0000244|PDB:3DLJ}.
FT   STRAND       99    101       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      107    109       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      113    118       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      126    132       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       140    142       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      152    154       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      157    160       {ECO:0000244|PDB:3DLJ}.
FT   TURN        161    166       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       167    182       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      188    197       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       199    201       {ECO:0000244|PDB:3DLJ}.
FT   TURN        202    205       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       206    213       {ECO:0000244|PDB:3DLJ}.
FT   TURN        214    217       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      223    226       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      238    243       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      245    255       {ECO:0000244|PDB:3DLJ}.
FT   TURN        262    264       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       272    280       {ECO:0000244|PDB:3DLJ}.
FT   TURN        293    298       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       304    311       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       317    324       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       334    342       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      346    355       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      358    360       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      367    377       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       383    399       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      404    415       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       425    438       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      443    449       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       452    460       {ECO:0000244|PDB:3DLJ}.
FT   STRAND      483    485       {ECO:0000244|PDB:3DLJ}.
FT   HELIX       486    504       {ECO:0000244|PDB:3DLJ}.
SQ   SEQUENCE   507 AA;  56706 MW;  756CCD872996F192 CRC64;
     MDPKLGRMAA SLLAVLLLLL ERGMFSSPSP PPALLEKVFQ YIDLHQDEFV QTLKEWVAIE
     SDSVQPVPRF RQELFRMMAV AADTLQRLGA RVASVDMGPQ QLPDGQSLPI PPIILAELGS
     DPTKGTVCFY GHLDVQPADR GDGWLTDPYV LTEVDGKLYG RGATDNKGPV LAWINAVSAF
     RALEQDLPVN IKFIIEGMEE AGSVALEELV EKEKDRFFSG VDYIVISDNL WISQRKPAIT
     YGTRGNSYFM VEVKCRDQDF HSGTFGGILH EPMADLVALL GSLVDSSGHI LVPGIYDEVV
     PLTEEEINTY KAIHLDLEEY RNSSRVEKFL FDTKEEILMH LWRYPSLSIH GIEGAFDEPG
     TKTVIPGRVI GKFSIRLVPH MNVSAVEKQV TRHLEDVFSK RNSSNKMVVS MTLGLHPWIA
     NIDDTQYLAA KRAIRTVFGT EPDMIRDGST IPIAKMFQEI VHKSVVLIPL GAVDDGEHSQ
     NEKINRWNYI EGTKLFAAFF LEMAQLH
//
